FARALLON CAPITAL MANAGEMENT, L.L.C.
Follow13F filer, CIK 909661, SAN FRANCISCO, CA
FARALLON CAPITAL MANAGEMENT, L.L.C. reported $21,675,731,270 across 89 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 55.71% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000908834-26-000432
- Period
- 2026-06-30
- Reported value
- $21.7B
- Holdings
- 89
- Top 10 weight
- 55.71%
- New
- 23
- Sold out
- 107
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMVTadded | +4,259,000 | $164M |
| ROIVadded | +4,634,000 | $164M |
| BSXadded | +3,050,500 | $130M |
| BBIOadded | +1,377,600 | $103M |
| TNGXadded | +3,179,589 | $99.4M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MSFTreduced | -1,231,916 | -$460M |
| AMZNreduced | -1,585,400 | -$378M |
| AONreduced | -1,130,076 | -$375M |
| SCHWexited | -3,955,657 | -$372M |
| GOOGexited | -996,231 | -$286M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0000908834-26-000432, largest first. % of portfolio is the value over $17,083,392,470, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 13,550,796 | $2.54B | 14.86% | -54,000 | Timeline | ||
| EAELECTRONIC ARTS INC | 7,919,500 | $1.62B | 9.51% | +449,500 | Timeline | ||
| BBIOBRIDGEBIO PHARMA INC | 10,743,063 | $800M | 4.68% | +1,377,600 | Timeline | ||
| PTGXPROTAGONIST THERAPEUTICS INC | 6,348,906 | $778M | 4.56% | 0 | Timeline | ||
| EXELEXELIXIS INC | 13,468,010 | $733M | 4.29% | +357,000 | Timeline | ||
| LQDALIQUIDIA CORPORATION | 8,365,038 | $667M | 3.9% | -291,000 | Timeline | ||
| AMZNAMAZON COM INC | 2,632,994 | $628M | 3.67% | -1,585,400 | Timeline | ||
| LNTHLANTHEUS HLDGS INC | 5,583,479 | $619M | 3.63% | 0 | Timeline | ||
| NTRANATERA INC | 2,218,366 | $602M | 3.52% | -989,000 | Timeline | ||
| UNHUNITEDHEALTH GROUP INC | 1,270,532 | $528M | 3.09% | -551,174 | Timeline | ||
| TMOTHERMO FISHER SCIENTIFIC INC | 1,049,185 | $526M | 3.08% | +167,700 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 14,309,000 | $506M | 2.96% | +4,634,000 | Timeline | ||
| AONAON PLC | 1,382,562 | $459M | 2.68% | -1,130,076 | Timeline | ||
| BSXBOSTON SCIENTIFIC CORP | 10,521,184 | $449M | 2.63% | +3,050,500 | Timeline | ||
| AVGOBROADCOM INC | 1,151,800 | $435M | 2.55% | -627,700 | Timeline | ||
| MSFTMICROSOFT CORP | 1,112,863 | $415M | 2.43% | -1,231,916 | Timeline | ||
| TNGXTANGO THERAPEUTICS INC | 12,277,000 | $384M | 2.25% | +3,179,589 | Timeline | ||
| KKRKKR & CO INC | 4,118,300 | $378M | 2.21% | -553,500 | Timeline | ||
| SNPSSYNOPSYS INC | 829,600 | $370M | 2.17% | -383,700 | Timeline | ||
| BEAMBEAM THERAPEUTICS INC | 10,236,396 | $351M | 2.06% | +101,700 | Timeline | ||
| CRNXCRINETICS PHARMACEUTICALS IN | 8,989,098 | $336M | 1.97% | +651,000 | Timeline | ||
| GRALGRAIL INC | 4,161,584 | $284M | 1.66% | +907,900 | Timeline | ||
| WABWABTEC | 894,503 | $241M | 1.41% | -714,900 | Timeline | ||
| IMVTIMMUNOVANT INC | 5,805,000 | $224M | 1.31% | +4,259,000 | Timeline | ||
| TWSTTWIST BIOSCIENCE CORP | 2,136,400 | $220M | 1.29% | +708,750 | Timeline | ||
| AGIOAGIOS PHARMACEUTICALS INC | 5,917,400 | $220M | 1.29% | +233,400 | Timeline | ||
| ARMKARAMARK | 3,625,731 | $206M | 1.21% | -2,509,700 | Timeline | ||
| BIDUBAIDU INC | 1,203,785 | $138M | 0.81% | +760,000 | Timeline | ||
| NVONOVO-NORDISK A S | 2,619,000 | $126M | 0.73% | +1,837,000 | Timeline | ||
| ACHCACADIA HEALTHCARE COMPANY IN | 4,220,800 | $125M | 0.73% | +2,484,000 | Timeline | ||
| BTSGBRIGHTSPRING HEALTH SVCS INC | 1,732,800 | $121M | 0.71% | +115,800 | Timeline | ||
| AZNASTRAZENECA PLC | 574,000 | $109M | 0.64% | +347,501 | Timeline | ||
| JNJJOHNSON & JOHNSON | 408,000 | $104M | 0.61% | +260,000 | Timeline | ||
| PBLSPARABILIS MEDICINES INC | 2,368,200 | $64.8M | 0.38% | new | Timeline | ||
| NVSNOVARTIS AG | 363,000 | $56.9M | 0.33% | new | Timeline | ||
| GHGUARDANT HEALTH INC | 322,200 | $48.3M | 0.28% | +314,200 | Timeline | ||
| AVTXAVALO THERAPEUTICS INC | 2,498,000 | $46.2M | 0.27% | +1,582,000 | Timeline | ||
| JOYYJOYY INC | 699,200 | $46.1M | 0.27% | +121,000 | Timeline | ||
| ASMBASSEMBLY BIOSCIENCES INC | 1,604,590 | $44.1M | 0.26% | +377,000 | Timeline | ||
| ENTAENANTA PHARMACEUTICALS INC | 2,418,202 | $35.3M | 0.21% | -453,660 | Timeline | ||
| MAZEMAZE THERAPEUTICS INC | 1,107,814 | $33.1M | 0.19% | +734,814 | Timeline | ||
| MRKMERCK & CO INC | 199,000 | $25.6M | 0.15% | -162,000 | Timeline | ||
| WRBYWARBY PARKER INC | 828,000 | $25.1M | 0.15% | new | Timeline | ||
| FRNMPERCEPTIVE CAP SOLUTIONS COR | 2,250,000 | $24.5M | 0.14% | 0 | Timeline | ||
| KLRAKAILERA THERAPEUTICS INC | 1,100,000 | $24.2M | 0.14% | new | Timeline | ||
| RIORIO TINTO PLC | 183,475 | $17.4M | 0.1% | +129,675 | Timeline | ||
| AXTAAXALTA COATING SYS LTD | 478,000 | $16.4M | 0.1% | new | Timeline | ||
| ABVXABIVAX SA | 122,000 | $16.3M | 0.1% | +120,000 | Timeline | ||
| VNETVNET GROUP INC | 1,992,000 | $16M | 0.09% | +1,368,653 | Timeline | ||
| NTESNETEASE COM INC | 123,500 | $15.8M | 0.09% | -167,719 | Timeline | ||
| BIIBBIOGEN INC | 71,000 | $15.3M | 0.09% | new | Timeline | ||
| TSHATAYSHA GENE THERAPIES INC | 2,250,000 | $15.3M | 0.09% | new | Timeline | ||
| MOBIMOBIA MED INC | 1,128,557 | $15.1M | 0.09% | new | Timeline | ||
| NERVMINERVA NEUROSCIENCES INC | 2,365,000 | $13.1M | 0.08% | 0 | Timeline | ||
| ALMRALAMAR BIOSCIENCES INC | 462,900 | $12.5M | 0.07% | new | Timeline | ||
| ALVOALVOTECH | 2,859,675 | $10.6M | 0.06% | +2,660,000 | Timeline | ||
| BBNXBETA BIONICS INC | 595,000 | $9.32M | 0.05% | -3,012,920 | Timeline | ||
| IFRXINFLARX NV | 3,325,000 | $7.45M | 0.04% | new | Timeline | ||
| SMGSCOTTS MIRACLE-GRO CO | 88,000 | $5.99M | 0.04% | new | Timeline | ||
| WAYWAYSTAR HLDG CORP | 264,900 | $5.44M | 0.03% | new | Timeline | ||
| BCBRUNSWICK CORP | 61,000 | $5.14M | 0.03% | new | Timeline | ||
| GNTXGENTEX CORP | 199,000 | $5.03M | 0.03% | new | Timeline | ||
| IDXXIDEXX LABS INC | 9,000 | $4.74M | 0.03% | new | Timeline | ||
| PRMEPRIME MEDICINE INC | 1,240,843 | $4.58M | 0.03% | 0 | Timeline | ||
| CMCCOMMERCIAL METALS CO | 67,000 | $4.2M | 0.02% | new | Timeline | ||
| JATTJATT II ACQUISITION CORP | 300,000 | $3.41M | 0.02% | new | Timeline | ||
| SGMTSAGIMET BIOSCIENCES INC | 415,000 | $3.21M | 0.02% | new | Timeline | ||
| SMCSUMMIT MIDSTREAM CORPORATION | 58,214 | $1.66M | 0.01% | 0 | Timeline | ||
| TEVATEVA PHARMACEUTICAL INDS LTD | 40,000 | $1.36M | 0.01% | -314,000 | Timeline | ||
| RVMDWREVOLUTION MEDICINES INC | 120,085 | $1.13M | 0.01% | 0 | Timeline | ||
| COGTCOGENT BIOSCIENCES INC | 17,000 | $658K | <0.01% | 0 | Timeline | ||
| ANNAWALEANNA INC | 990,000 | $297K | <0.01% | 0 | Timeline | ||
| ANNAALEANNA INC | 78,400 | $227K | <0.01% | 0 | Timeline | ||
| WELLWELLTOWER INC | 1,000 | $227K | <0.01% | -199,000 | Timeline | ||
| SLDPWSOLID POWER INC | 405,316 | $41.4K | <0.01% | 0 | Timeline | ||
| BGLWWBLUE GOLD LTD | 255,800 | $30.7K | <0.01% | -44,200 | Timeline | ||
| PACBPACIFIC BIOSCIENCES CALIF IN | 14,200 | $23.9K | <0.01% | -120,800 | Timeline | ||
| GERNGERON CORP | 14,400 | $18.4K | <0.01% | -28,600 | Timeline | ||
| NVNIWNVNI GROUP LIMITED | 375,000 | $17.6K | <0.01% | 0 | Timeline | ||
| CGCCANOPY GROWTH CORPORATION | 18,000 | $17.1K | <0.01% | -12,000 | Timeline | ||
| RANIRANI THERAPEUTICS HLDGS INC | 20,700 | $15.7K | <0.01% | -57,300 | Timeline | ||
| BYNDBEYOND MEAT INC | 19,000 | $14.2K | <0.01% | 0 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| STRATEGY INCSTRATEGY INC NOTE12/0 | principal | 87,858,000 | $75.4M | +48,358,000 |
| VNET GROUP INCVNET GROUP INC NOTE 2.000%10/0 | principal | 45,000,000 | $46.8M | 0 |
| STRATEGY INCSTRATEGY INC NOTE 2.250% 6/1 | principal | 15,000,000 | $14.2M | new |
| STRATEGY INCSTRATEGY INC NOTE 3/0 | principal | 2,632,000 | $2.32M | new |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
The largest 100 of 107. All 107
| Security | Shares before | Value before | Type |
|---|---|---|---|
| STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T | 2,300,000 | $1.5B | put |
| INVESCO EXCHANGE TRADED FD TINVESCO EXCHANGE TRADED FD T | 3,600,000 | $691M | put |
| SCHWCHARLES SCHWAB CORP (THE) | 3,955,657 | $372M | shares |
| GOOGALPHABET INC | 996,231 | $286M | shares |
| VVISA INC | 840,710 | $254M | shares |
| DISDISNEY WALT CO | 2,401,591 | $231M | shares |
| MAMASTERCARD INCORPORATED | 435,071 | $217M | shares |
| MCKMCKESSON CORP | 234,300 | $203M | shares |
| CNTACENTESSA PHARMACEUTICALS PLC | 4,809,000 | $191M | shares |
| TYRATYRA BIOSCIENCES INC | 3,580,818 | $137M | shares |
| THCTENET HEALTHCARE CORP | 452,153 | $85.3M | shares |
| CAHCARDINAL HEALTH INC | 368,000 | $77.8M | shares |
| PCVXVAXCYTE INC | 1,261,000 | $73.3M | shares |
| DNTHDIANTHUS THERAPEUTICS INC | 836,000 | $70.2M | shares |
| CGONCG ONCOLOGY INC | 674,000 | $45.6M | shares |
| BITWBITWISE 10 CRYPTO INDEX ETF | 603,000 | $26.9M | shares |
| RPRXROYALTY PHARMA PLC | 493,000 | $23.6M | shares |
| CECOCECO ENVIRONMENTAL CORP | 234,000 | $13.9M | shares |
| CG ONCOLOGY INCCG ONCOLOGY INC | 200,000 | $13.5M | call |
| GDSGDS HLDGS LTD | 292,000 | $11.8M | shares |
| FORMFORMFACTOR INC | 56,500 | $5.48M | shares |
| MTZMASTEC INC | 17,000 | $5.47M | shares |
| ENTGENTEGRIS INC | 45,500 | $5.33M | shares |
| CCITIGROUP INC | 47,000 | $5.33M | shares |
| HHYATT HOTELS CORP | 36,000 | $5.18M | shares |
| WALWESTERN ALLIANCE BANCORP | 73,000 | $5.17M | shares |
| TKRTIMKEN CO | 51,000 | $5.13M | shares |
| FLEXFLEX LTD | 78,000 | $5.11M | shares |
| SPGIS&P GLOBAL INC | 12,000 | $5.1M | shares |
| LFUSLITTELFUSE INC | 15,000 | $5.09M | shares |
| PIPRPIPER SANDLER COMPANIES | 66,000 | $5.05M | shares |
| AIRAAR CORP | 46,000 | $5.04M | shares |
| GTXGARRETT MOTION INC | 275,000 | $5M | shares |
| ROLROLLINS INC | 93,000 | $4.97M | shares |
| AFRMAFFIRM HLDGS INC | 108,000 | $4.95M | shares |
| INTRINTER & CO INC | 614,500 | $4.89M | shares |
| CMICUMMINS INC | 9,000 | $4.84M | shares |
| FISVFISERV INC | 86,000 | $4.8M | shares |
| VRTVERTIV HOLDINGS CO | 19,000 | $4.76M | shares |
| AMKRAMKOR TECHNOLOGY INC | 104,000 | $4.68M | shares |
| RNAATRIUM THERAPEUTICS INC | 349,360 | $4.67M | shares |
| GFSGLOBALFOUNDRIES INC | 105,000 | $4.67M | shares |
| MOHMOLINA HEALTHCARE INC | 35,000 | $4.67M | shares |
| IRDOPUS GENETICS INC | 1,000,000 | $4.55M | shares |
| TENBTENABLE HLDGS INC | 265,000 | $4.48M | shares |
| NOWSERVICENOW INC | 41,000 | $4.29M | shares |
| MDGLMADRIGAL PHARMACEUTICALS INC | 3,319 | $1.74M | shares |
| CAPRCAPRICOR THERAPEUTICS INC | 41,000 | $1.25M | shares |
| ARWRARROWHEAD PHARMACEUTICALS IN | 15,800 | $991K | shares |
| ALKSALKERMES PLC | 20,800 | $735K | shares |
| AXSMAXSOME THERAPEUTICS INC. | 4,000 | $676K | shares |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 26,000 | $613K | shares |
| CELCCELCUITY INC | 4,000 | $457K | shares |
| LIVNLIVANOVA PLC | 6,000 | $381K | shares |
| TERNTERNS PHARMACEUTICALS INC | 7,000 | $369K | shares |
| IONSIONIS PHARMACEUTICALS INC | 4,800 | $360K | shares |
| TVTXTRAVERE THERAPEUTICS INC | 12,000 | $357K | shares |
| GMEDGLOBUS MED INC | 4,000 | $345K | shares |
| SRRKSCHOLAR ROCK HLDG CORP | 7,000 | $344K | shares |
| ONCBEONE MEDICINES LTD | 1,100 | $327K | shares |
| WGSGENEDX HOLDINGS CORP | 5,000 | $321K | shares |
| CORCENCORA INC | 1,000 | $314K | shares |
| NUVLNUVALENT INC | 3,000 | $307K | shares |
| PGNYPROGYNY INC | 18,000 | $306K | shares |
| STOKSTOKE THERAPEUTICS INC | 9,000 | $293K | shares |
| ERASERASCA INC | 18,000 | $291K | shares |
| EHCENCOMPASS HEALTH CORP | 3,000 | $290K | shares |
| NKTRNEKTAR THERAPEUTICS | 4,000 | $288K | shares |
| GKOSGLAUKOS CORP | 2,600 | $280K | shares |
| MIRMMIRUM PHARMACEUTICALS INC | 3,000 | $277K | shares |
| SBRASABRA HEALTH CARE REIT INC | 14,000 | $269K | shares |
| KRYSKRYSTAL BIOTECH INC | 1,000 | $258K | shares |
| OMEROMEROS CORP | 23,000 | $243K | shares |
| ALMSALUMIS INC | 11,000 | $242K | shares |
| APLSAPELLIS PHARMACEUTICALS INC | 6,000 | $241K | shares |
| HQYHEALTHEQUITY INC | 2,800 | $234K | shares |
| SNDXSYNDAX PHARMACEUTICALS INC | 10,000 | $234K | shares |
| FOLDAMICUS THERAPEUTIC | 16,000 | $231K | shares |
| QUREUNIQURE NV | 14,000 | $229K | shares |
| BCRXBIOCRYST PHARMACEUTICALS INC | 24,000 | $228K | shares |
| VCYTVERACYTE INC | 7,000 | $225K | shares |
| GRFSGRIFOLS S A | 28,000 | $225K | shares |
| GEHCGE HEALTHCARE TECHNOLOGIES I | 3,000 | $214K | shares |
| HIMSHIMS & HERS HEALTH INC | 10,000 | $208K | shares |
| BLTEBELITE BIO INC | 1,300 | $207K | shares |
| MMSIMERIT MED SYS INC | 3,000 | $207K | shares |
| SUPNSUPERNUS PHARMACEUTICALS | 4,000 | $207K | shares |
| HRHEALTHCARE RLTY TR | 12,000 | $204K | shares |
| URGNUROGEN PHARMA LTD | 11,000 | $198K | shares |
| VIRVIR BIOTECHNOLOGY INC | 22,000 | $197K | shares |
| PGENPRECIGEN INC | 50,000 | $194K | shares |
| SDGRSCHRODINGER INC | 17,000 | $193K | shares |
| DYNDYNE THERAPEUTICS INC | 10,000 | $181K | shares |
| NVAXNOVAVAX INC | 22,000 | $179K | shares |
| SLSSELLAS LIFE SCIENCES GROUP I | 40,000 | $169K | shares |
| ADPTADAPTIVE BIOTECHNOLOGIES COR | 11,000 | $153K | shares |
| OCULOCULAR THERAPEUTIX INC | 18,000 | $152K | shares |
| NEONEOGENOMICS INC | 19,000 | $141K | shares |
| ARDXARDELYX INC | 23,000 | $138K | shares |
| OSCROSCAR HEALTH INC | 11,000 | $126K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000908834-26-000432 | base | 2026-08-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner. The newest 100 of 155.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR/A 0000908834-26-000434 | Quarter ended 2026-03-31 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-26-000433 | Quarter ended 2025-12-31 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-26-000432 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-26-000240 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-26-000241 | Quarter ended 2025-12-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-26-000086 | Quarter ended 2025-09-30 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-26-000087 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-26-000083 | Quarter ended 2024-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-26-000084 | Quarter ended 2025-03-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-26-000085 | Quarter ended 2025-06-30 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000346 | Quarter ended 2023-12-31 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000350 | Quarter ended 2024-12-31 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000347 | Quarter ended 2024-03-31 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000351 | Quarter ended 2025-03-31 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000345 | Quarter ended 2023-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000352 | Quarter ended 2025-06-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000349 | Quarter ended 2024-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000348 | Quarter ended 2024-06-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-25-000353 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000244 | Quarter ended 2024-03-31 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000243 | Quarter ended 2024-09-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000245 | Quarter ended 2024-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000247 | Quarter ended 2025-03-31 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000246 | Quarter ended 2024-12-31 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000250 | Quarter ended 2023-12-31 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-25-000248 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000180 | Quarter ended 2024-12-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-25-000177 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000179 | Quarter ended 2024-09-30 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000178 | Quarter ended 2024-06-30 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000078 | Quarter ended 2024-03-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-25-000081 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000079 | Quarter ended 2024-06-30 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-25-000080 | Quarter ended 2024-09-30 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000324 | Quarter ended 2024-06-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-24-000307 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000202 | Quarter ended 2024-03-31 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-24-000200 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000159 | Quarter ended 2024-03-31 | 2024-05-24 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-24-000135 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000141 | Quarter ended 2023-12-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000138 | Quarter ended 2023-09-30 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000073 | Quarter ended 2022-09-30 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000074 | Quarter ended 2022-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-24-000070 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000077 | Quarter ended 2023-09-30 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000081 | Quarter ended 2022-06-30 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000075 | Quarter ended 2023-03-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000076 | Quarter ended 2023-06-30 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-24-000049 | Quarter ended 2023-09-30 | 2024-02-12 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000154 | Quarter ended 2022-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000152 | Quarter ended 2022-03-31 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000156 | Quarter ended 2023-03-31 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-23-000150 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000157 | Quarter ended 2023-06-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000155 | Quarter ended 2022-12-31 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000153 | Quarter ended 2022-06-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000134 | Quarter ended 2023-06-30 | 2023-10-26 | acceptance time not in the bulk data set | |
| 13F-HR 0000908834-23-000109 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000908834-23-000110 | Quarter ended 2023-03-31 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000134 | Quarter ended 2022-06-30 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000136 | Quarter ended 2022-12-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000130 | Quarter ended 2021-06-30 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001175707-23-000127 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000133 | Quarter ended 2022-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000135 | Quarter ended 2022-09-30 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000132 | Quarter ended 2021-12-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001175707-23-000131 | Quarter ended 2021-09-30 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000909661-23-000003 | Quarter ended 2022-06-30 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000909661-23-000002 | Quarter ended 2022-03-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001175707-23-000051 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000909661-23-000005 | Quarter ended 2022-09-30 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-019862 | Quarter ended 2022-06-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001567619-22-019851 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-019864 | Quarter ended 2022-03-31 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-019852 | Quarter ended 2021-12-31 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-015962 | Quarter ended 2021-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-015972 | Quarter ended 2022-03-31 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-015968 | Quarter ended 2021-12-31 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-015957 | Quarter ended 2021-03-31 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001567619-22-015953 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-015964 | Quarter ended 2021-09-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-011257 | Quarter ended 2021-12-31 | 2022-05-19 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-011256 | Quarter ended 2021-09-30 | 2022-05-19 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-011255 | Quarter ended 2021-06-30 | 2022-05-19 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-011254 | Quarter ended 2021-03-31 | 2022-05-19 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-010741 | Quarter ended 2020-12-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-010746 | Quarter ended 2021-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-010750 | Quarter ended 2021-06-30 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-010757 | Quarter ended 2021-12-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001567619-22-010736 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-010753 | Quarter ended 2021-09-30 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-003981 | Quarter ended 2021-09-30 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001567619-22-003965 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-003973 | Quarter ended 2021-06-30 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-22-003970 | Quarter ended 2021-03-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-21-015168 | Quarter ended 2021-09-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-21-015176 | Quarter ended 2021-06-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-21-015180 | Quarter ended 2020-09-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-21-015169 | Quarter ended 2021-03-31 | 2021-11-15 | acceptance time not in the bulk data set |